Zobrazeno 1 - 7
of 7
pro vyhledávání: '"39"'
Autor:
Luis Antonio Luizaga, Cristina Caupena, Roser Costa, Ramón Rami-Porta, Raquel Albero-González, Sergi Call, Francisco Pérez-Ochoa, Carme Obiols, Xavier Tarroch, Lluis Esteban, Mireia Serra, José Sanz-Santos, Àngels Jaen, Josep Belda
Publikováno v:
Medicine
In non-small cell lung cancer (NSCLC) patients, the recommended minimum requirement for an endoscopy-based mediastinal staging procedure is sampling the largest lymph node (LN) in right and left inferior paratracheal, and subcarinal stations. We aime
Publikováno v:
Medicine
Sorafenib is of proven efficacy in treating patients of hepatocellular carcinoma (HCC). Our study was aimed to determine the factors influence the sorafenib efficacy. We evaluated data of HCC patients receiving sorafenib from June 2012 to October 201
Autor:
Yiping Luo, Ming Chen, Aibing Wu, Shujun Li, Zhixiong Yang, Donghong Yang, Hua Tao, Hualin Chen
Publikováno v:
Medicine
To examine the outcomes of concurrent versus sequential whole-brain radiotherapy (WBRT) and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer (NSCLC) patients with EGFR mutation. Retrospectively 105 pa
Autor:
Younan Liu, Lidong Liu, Xuna Zhu, Guanqiao Jin, Danke Su, Chen Wang, Ningbin Luo, Shao-Lv Lai
Publikováno v:
Medicine
Tumor recurrence is a major cause of nasopharyngeal carcinoma (NPC) treatment failure. Diffusion-weighted imaging (DWI) is used for a variety of cancers, but few data are available for NPC. The aim of the study was to investigate the DWI features of
Publikováno v:
Medicine
The long-term survival benefit of treating unresectable hepatocellular carcinoma (HCC) patients with transarterial chemoembolization (TACE) rather than conservative treatment remains controversial. This retrospective case-control study evaluated the
Publikováno v:
Medicine
To compare the clinical efficacies and adverse reactions between transcatheter arterial chemoembolization (TACE), γ-ray 3-dimensional fractionated stereotactic conformal radiotherapy (FSCR), and TACE combined with FSCR for primary hepatocellular car
Autor:
Xuemei Ding, Xiao-Long Li, Shi-Gang Guo, Shan Ke, Jun Gao, Jian Kong, Chun-Min Ning, Yong-Hong Dong, Hai-Gang Niu, Long Zhang, Wenbing Sun, Zong-Hai Xin
Publikováno v:
Medicine
This study investigated the effectiveness of a new strategy, repeated radiofrequency (RF) ablation combined with ablated lesion elimination following transarterial chemoembolization (TACE)/transarterial embolization (TAE), for solitary huge hepatocel